Evidence map›Paper›PMID 30577665›Full record

ArticleJournal of clinical medicine2018

Metabolic Signature Differentiated Diabetes Mellitus from Lipid Disorder in Elderly Taiwanese.

Chi-Jen Lo, Hsiang-Yu Tang, Cheng-Yu Huang, Chih-Ming Lin, Hung-Yao Ho, Ming-Shi Shiao, Mei-Ling Cheng

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chi-Jen LoMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. chijenlo@gmail.com.ORCID 0000-0003-4439-8033
Hsiang-Yu TangMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. tangshyu@gmail.com.ORCID 0000-0002-2536-6370
Cheng-Yu HuangMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. chenyu7015@gmail.com.
Chih-Ming LinDivision of Internal Medicine, Chang Gung Memorial Hospital, Taipei 105, Taiwan. lin789@adm.cgmh.org.tw.
Hung-Yao HoMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. hoh01@mail.cgu.edu.tw.
Ming-Shi ShiaoMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. msshiao@gap.cgu.edu.tw.
Mei-Ling ChengMetabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan City 333, Taiwan. chengm@mail.cgu.edu.tw.ORCID 0000-0003-2006-133X
Chang Gung University · TWChang Gung University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is a complex progression of biological processes and is the causal contributor to the development of diabetes mellitus (DM). DM is the most common degenerative disease and is the fifth leading cause of death in Taiwan, where the trend of DM mortality has been steadily increasing. Metabolomics, important branch of systems biology, has been mainly utilized to understand endogenous metabolites in biological systems and their dynamic changes as they relate to endogenous and exogenous factors. The purpose of this study was to elucidate the metabolomic profiles in elderly people and its relation to lipid disorder (LD). We collected 486 elderly individuals aged ≥65 years and performed untargeted and targeted metabolite analysis using nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-mass spectrometry (LC/MS). Several metabolites, including branched-chain amino acids, alanine, glutamate and alpha-aminoadipic acid were elevated in LD compared to the control group. Based on multivariate analysis, four metabolites were selected in the best model to predict DM progression: phosphatidylcholine acyl-alkyl (PC ae) C34:3, PC ae C44:3, SM C24:1 and PCae C36:3. The combined area under the curve (AUC) of those metabolites (0.82) was better for DM classification than individual values. This study found that targeted metabolic signatures not only distinguish the LD within the control group but also differentiated DM from LD in elderly Taiwanese. These metabolites could indicate the nutritional status and act as potential metabolic biomarkers for the elderly in Taiwan.

Indexed as

diabetes mellituselderlylipid disordermetabolomics

Identifiers

PMID30577665
PMCPMC6352219
OpenAlexW2905951300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.